BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koh TJ, Chen D. Gastrin as a growth factor in the gastrointestinal tract. Regul Pept. 2000;93:37-44. [PMID: 11033051 DOI: 10.1016/s0167-0115(00)00176-2] [Cited by in Crossref: 73] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Xiao L, Kovac S, Chang M, Shulkes A, Baldwin GS, Patel O. Induction of gastrin expression in gastrointestinal cells by hypoxia or cobalt is independent of hypoxia-inducible factor (HIF). Endocrinology 2012;153:3006-16. [PMID: 22593272 DOI: 10.1210/en.2011-2069] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
2 Vaziri F, Tarashi S, Fateh A, Siadat SD. New insights of Helicobacter pylori host-pathogen interactions: The triangle of virulence factors, epigenetic modifications and non-coding RNAs. World J Clin Cases 2018;6:64-73. [PMID: 29774218 DOI: 10.12998/wjcc.v6.i5.64] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Han YM, Hahm KB, Park JM, Hong SP, Kim EH. Paradoxically augmented anti-tumorigenic action of proton pump inhibitor and GastrininAPCMin/+ intestinal polyposis model. Neoplasia 2014;16:73-83. [PMID: 24563620 DOI: 10.1593/neo.131510] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
4 Bayraktaroğlu T, Aras AS, Aydemir S, Davutoğlu C, Ustündağ Y, Atmaca H, Borazan A. Serum levels of tumor necrosis factor-alpha, interleukin-6 and interleukin-8 are not increased in dyspeptic patients with Helicobacter pylori-associated gastritis. Mediators Inflamm 2004;13:25-8. [PMID: 15203561 DOI: 10.1080/09629350410001664789] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
5 Webb DL, Rudholm-Feldreich T, Gillberg L, Halim MA, Theodorsson E, Sanger GJ, Campbell CA, Boyce M, Näslund E, Hellström PM. The type 2 CCK/gastrin receptor antagonist YF476 acutely prevents NSAID-induced gastric ulceration while increasing iNOS expression. Naunyn Schmiedebergs Arch Pharmacol 2013;386:41-9. [PMID: 23179899 DOI: 10.1007/s00210-012-0812-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
6 Xiong XH, Zhao HL, Xue C, Zhang W, Yang BF, Yao XQ, Liu ZM. Construction and evaluation of anti-gastrin immunogen based on P64K protein. World J Gastroenterol 2006;12:2040-6. [PMID: 16610054 DOI: 10.3748/wjg.v12.i13.2040] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Kohli M, Tan W, Vire B, Liaud P, Blairvacq M, Berthier F, Rouison D, Garnier G, Payen L, Cousin T, Joubert D, Prieur A. Prognostic Value of Plasma hPG80 (Circulating Progastrin) in Metastatic Renal Cell Carcinoma. Cancers (Basel) 2021;13:375. [PMID: 33498444 DOI: 10.3390/cancers13030375] [Reference Citation Analysis]
8 Huynh N, Liu KH, Yim M, Shulkes A, Baldwin GS, He H. Demonstration and biological significance of a gastrin-P21-activated kinase 1 feedback loop in colorectal cancer cells. Physiol Rep 2014;2:e12048. [PMID: 24963032 DOI: 10.14814/phy2.12048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
9 Jin G, Ramanathan V, Quante M, Baik GH, Yang X, Wang SS, Tu S, Gordon SA, Pritchard DM, Varro A, Shulkes A, Wang TC. Inactivating cholecystokinin-2 receptor inhibits progastrin-dependent colonic crypt fission, proliferation, and colorectal cancer in mice. J Clin Invest 2009;119:2691-701. [PMID: 19652364 DOI: 10.1172/JCI38918] [Cited by in Crossref: 9] [Cited by in F6Publishing: 39] [Article Influence: 0.8] [Reference Citation Analysis]
10 Sun FP, Song YG. G and D cells in rat antral mucosa: an immunoelectron microscopic study. World J Gastroenterol 2003;9:2768-71. [PMID: 14669330 DOI: 10.3748/wjg.v9.i12.2768] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
11 Berna MJ, Jensen RT. Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases. Curr Top Med Chem. 2007;7:1211-1231. [PMID: 17584143 DOI: 10.2174/156802607780960519] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
12 Zelter A, Fernández JL, Bilder C, Rodríguez P, Wonaga A, Dorado F, Galich M, Viola LA. Fundic gland polyps and association with proton pump inhibitor intake: a prospective study in 1,780 endoscopies. Dig Dis Sci. 2011;56:1743-1748. [PMID: 21127978 DOI: 10.1007/s10620-010-1493-x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
13 Ally MR, Veerappan GR, Maydonovitch CL, Duncan TJ, Perry JL, Osgard EM, Wong RK. Chronic proton pump inhibitor therapy associated with increased development of fundic gland polyps. Dig Dis Sci. 2009;54:2617-2622. [PMID: 19830554 DOI: 10.1007/s10620-009-0993-z] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
14 Masià-Balagué M, Izquierdo I, Garrido G, Cordomí A, Pérez-Benito L, Miller NL, Schlaepfer DD, Gigoux V, Aragay AM. Gastrin-stimulated Gα13 Activation of Rgnef Protein (ArhGEF28) in DLD-1 Colon Carcinoma Cells. J Biol Chem 2015;290:15197-209. [PMID: 25922072 DOI: 10.1074/jbc.M114.628164] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
15 Yao M, Song DH, Rana B, Wolfe MM. COX-2 selective inhibition reverses the trophic properties of gastrin in colorectal cancer. Br J Cancer 2002;87:574-9. [PMID: 12189559 DOI: 10.1038/sj.bjc.6600495] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
16 Rabben HL, Zhao CM, Hayakawa Y, Wang TC, Chen D. Vagotomy and Gastric Tumorigenesis. Curr Neuropharmacol. 2016;14:967-972. [PMID: 26791481 DOI: 10.2174/1570159x14666160121114854] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
17 Hougaard DM, Larsson LI. Carboxypeptidase E in rat antropyloric mucosa: distribution in progenitor and mature endocrine cell types. Histochem Cell Biol 2004;121:55-61. [PMID: 14661109 DOI: 10.1007/s00418-003-0606-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
18 Ashktorab H, Ahmed A, Littleton G, Wang XW, Allen CR, Tackey R, Walters C, Smoot DT. p53 and p14 increase sensitivity of gastric cells to H. pylori-induced apoptosis. Dig Dis Sci 2003;48:1284-91. [PMID: 12870784 DOI: 10.1023/a:1024198807619] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
19 Cui G, Waldum HL. Physiological and clinical significance of enterochromaffin-like cell activation in the regulation of gastric acid secretion. World J Gastroenterol 2007;13:493-6. [PMID: 17278212 DOI: 10.3748/wjg.v13.i4.493] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
20 Sheh A, Fox JG. The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis. Gut Microbes. 2013;4:505-531. [PMID: 23962822 DOI: 10.4161/gmic.26205] [Cited by in Crossref: 102] [Cited by in F6Publishing: 83] [Article Influence: 12.8] [Reference Citation Analysis]
21 Bierkamp C, Bonhoure S, Mathieu A, Clerc P, Fourmy D, Pradayrol L, Seva C, Dufresne M. Expression of cholecystokinin-2/gastrin receptor in the murine pancreas modulates cell adhesion and cell differentiation in vivo. Am J Pathol 2004;165:2135-45. [PMID: 15579455 DOI: 10.1016/S0002-9440(10)63263-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
22 Watson SA, Grabowska AM, El-Zaatari M, Takhar A. Gastrin - active participant or bystander in gastric carcinogenesis? Nat Rev Cancer. 2006;6:936-946. [PMID: 17128210 DOI: 10.1038/nrc2014] [Cited by in Crossref: 92] [Cited by in F6Publishing: 75] [Article Influence: 6.6] [Reference Citation Analysis]
23 Krausch M, Raffel A, Anlauf M, Schott M, Lehwald N, Krieg A, Kröpil F, Cupisti K, Knoefel WT. Secondary malignancy in patients with sporadic neuroendocrine neoplasia. Endocrine 2013;44:510-6. [PMID: 23494366 DOI: 10.1007/s12020-013-9911-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
24 Sheng W, Malagola E, Nienhüser H, Zhang Z, Kim W, Zamechek L, Sepulveda A, Hata M, Hayakawa Y, Zhao CM, Chen D, Wang TC. Hypergastrinemia Expands Gastric ECL Cells Through CCK2R+ Progenitor Cells via ERK Activation. Cell Mol Gastroenterol Hepatol 2020;10:434-449.e1. [PMID: 32330731 DOI: 10.1016/j.jcmgh.2020.04.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
25 Blandizzi C, Tuccori M, Colucci R, Gori G, Fornai M, Antonioli L, Ghisu N, Del Tacca M. Clinical efficacy of esomeprazole in the prevention and healing of gastrointestinal toxicity associated with NSAIDs in elderly patients. Drugs Aging. 2008;25:197-208. [PMID: 18331072 DOI: 10.2165/00002512-200825030-00003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
26 Smith JP, Nadella S, Osborne N. Gastrin and Gastric Cancer. Cell Mol Gastroenterol Hepatol. 2017;4:75-83. [PMID: 28560291 DOI: 10.1016/j.jcmgh.2017.03.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
27 Amang AP, Mezui C, Siwe GT, Emakoua J, Mbah G, Nkwengoua EZ, Enow-Orock GE, Tan PV. Healing and Antisecretory Effects of Aqueous Extract of Eremomastax speciosa (Acanthaceae) on Unhealed Gastric Ulcers. Biomed Res Int 2017;2017:1924320. [PMID: 29234676 DOI: 10.1155/2017/1924320] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
28 Parker LA, Weaver M, Murgas Torrazza RJ, Shuster J, Li N, Krueger C, Neu J. Effect of Aspiration and Evaluation of Gastric Residuals on Intestinal Inflammation, Bleeding, and Gastrointestinal Peptide Level. J Pediatr 2020;217:165-171.e2. [PMID: 31757473 DOI: 10.1016/j.jpeds.2019.10.036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]